European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26068877%3A_____%2F25%3AN0000032" target="_blank" >RIV/26068877:_____/25:N0000032 - isvavai.cz</a>

Result on the web

<a href="https://www.sciencedirect.com/science/article/pii/S0302283825001812?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0302283825001812?via%3Dihub</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.eururo.2025.03.011" target="_blank" >10.1016/j.eururo.2025.03.011</a>

Result language

angličtina

Original language name

European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis

Original language description

Background and objective: The European Association of Urology urolithiasis guidelines provide evidence-based recommendations for the diagnosis and treatment of urinary stone disease. Given the complexity and variability of stone formation, individualised patient management is emphasised. Methods: The guidelines incorporate evidence from the latest research and focus on risk assessment, imaging techniques, pharmacological management, and surgical interventions. A research librarian conducted literature searches for urolithiasis in the Cochrane Library, Medline, and Embase databases via Dialog-Datastar. The strength of recommendations is also rated. Key findings and limitations: Diagnosis relies on a combination of clinical history, biochemical evaluation, and imaging, with ultrasound as the first-line modality and low-dose computed tomography as the gold standard for precise stone assessment. Stone composition and burden influence treatment decisions with algorithms primarily based on stone size, location, and composition. Nonsteroidal antiinflammatory drugs are recommended for first-line pain management, with opioids reserved as a secondary option. Medical expulsive therapy with a-blockers may be considered for selected patients with ureteral stones. Extracorporeal shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy remain the primary intervention modalities, with selection based on stone characteristics and patient ing is recommended for high-risk patients to guide personalised treatment. Conclusions and clinical implications: The guidelines provide a framework for clinical decision-making while acknowledging the need for continued advances in urolithiasis. (c) 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30217 - Urology and nephrology

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2025

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

EUROPEAN UROLOGY

ISSN

0302-2838

e-ISSN

1873-7560

Volume of the periodical

88

Issue of the periodical within the volume

1

Country of publishing house

NL - THE KINGDOM OF THE NETHERLANDS

Number of pages

12

Pages from-to

64-75

UT code for WoS article

001513127500016

EID of the result in the Scopus database

2-s2.0-105003288230